Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification.
Carbone D, Vestuto V, Ferraro MR, Ciaglia T, Pecoraro C, Sommella E, Cascioferro S, Salviati E, Novi S, Tecce MF, Amodio G, Iraci N, Cirrincione G, Campiglia P, Diana P, Bertamino A, Parrino B, Ostacolo C.
Carbone D, et al.
Eur J Med Chem. 2022 Apr 15;234:114233. doi: 10.1016/j.ejmech.2022.114233. Epub 2022 Mar 6.
Eur J Med Chem. 2022.
PMID: 35286926